News | September 09, 2007

Signalife Launches Sales of Ambulatory Heart Monitor

September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular monitor.
In private meetings throughout the United States over the next 10 days, the company's cardiovascular experts and Signalife's technology team will present the technologies to the several hospitals, facilities and physician-groups.
"We will be visiting more than a dozen hospitals with thousands of beds and hundreds of physicians, beginning now, in cities nationwide," said Lowell Harmison, CEO of Signalife.

For more information: www.signalife.com

Related Content

National Institute of Health Campus

Feature | June 06, 2013
The National Institutes of Health (NIH), the nation’s medical research agency and the leading supporter of biomedical...
News | April 16, 2012
April 16, 2012 — Philips Healthcare announced it is collaborating with Brainlab AG to create a comprehensive intra-...
Technology | February 24, 2011
February 24, 2011 – A percutaneous microwave tissue ablation (pMTA) system will be unveiled at the European Congress of...
News | August 12, 2008
August 13, 2008 - The University of Pennsylvania's School of Medicine will host a one-day medical education conferenc
News | November 03, 2007
November 4, 2007 - The prevalence of asymptomatic peripheral artery disease (PAD) is steadily increasing among Americ
News | September 11, 2007
September 12, 2007 - Cardica Inc.
Overlay Init